000 | 01898 a2200577 4500 | ||
---|---|---|---|
005 | 20250517071859.0 | ||
264 | 0 | _c20170911 | |
008 | 201709s 0 0 eng d | ||
022 | _a1938-3673 | ||
024 | 7 |
_a10.1189/jlb.5MA0815-388R _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaciejewski-Duval, Anna | |
245 | 0 | 0 |
_aAltered chemotactic response to CXCL12 in patients carrying GATA2 mutations. _h[electronic resource] |
260 |
_bJournal of leukocyte biology _c06 2016 |
||
300 |
_a1065-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aCD56 Antigen _xmetabolism |
650 | 0 | 4 |
_aCell Membrane _xdrug effects |
650 | 0 | 4 |
_aChemokine CXCL12 _xpharmacology |
650 | 0 | 4 |
_aChemotaxis _xdrug effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGATA2 Transcription Factor _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 |
_aReceptors, CXCR4 _xmetabolism |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aMeuris, Floriane | |
700 | 1 | _aBignon, Alexandre | |
700 | 1 | _aAknin, Marie-Laure | |
700 | 1 | _aBalabanian, Karl | |
700 | 1 | _aFaivre, Laurence | |
700 | 1 | _aPasquet, Marlène | |
700 | 1 | _aBarlogis, Vincent | |
700 | 1 | _aFieschi, Claire | |
700 | 1 | _aBellanné-Chantelot, Christine | |
700 | 1 | _aDonadieu, Jean | |
700 | 1 | _aSchlecht-Louf, Géraldine | |
700 | 1 | _aMarin-Esteban, Viviana | |
700 | 1 | _aBachelerie, Françoise | |
773 | 0 |
_tJournal of leukocyte biology _gvol. 99 _gno. 6 _gp. 1065-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1189/jlb.5MA0815-388R _zAvailable from publisher's website |
999 |
_c25581494 _d25581494 |